コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 rus to receptors present on the surface of a susceptible cell.
2 istant subpopulation in a main population of susceptible cells.
3 receptors is essential for HSV infection of susceptible cells.
4 seminate viral particles to target organs or susceptible cells.
5 rains of primate immunodeficiency viruses to susceptible cells.
6 ate RNA degradation in neurons than in other susceptible cells.
7 ogenic potential of the Env protein in other susceptible cells.
8 between highly susceptible cells and poorly susceptible cells.
9 TLV-1) on both highly susceptible and poorly susceptible cells.
10 s that were infectious when transfected into susceptible cells.
11 ng viral destabilization after attachment to susceptible cells.
12 onstrate that the drug inhibits infection of susceptible cells.
13 the ligands TNF-alpha and TRAIL to kill the susceptible cells.
14 tic cytopathic effect by forming syncytia in susceptible cells.
15 minate the inserted sequences upon spread in susceptible cells.
16 n the formation of cation-selective pores in susceptible cells.
17 coreceptors for entry of HIV-1 strains into susceptible cells.
18 ae that inhibits protein synthesis and kills susceptible cells.
19 through stimulation of apoptotic programs in susceptible cells.
20 le Tva proteins to inhibit ALV(A) entry into susceptible cells.
21 ixed populations of antibiotic-resistant and susceptible cells.
22 te for P. falciparum) within a population of susceptible cells.
23 inding to RI and RII, and of PKA activity in susceptible cells.
24 gion of p6(Gag), Y36S-L41P, could not infect susceptible cells.
25 -Fas antibodies rapidly induces apoptosis in susceptible cells.
26 ral genome from the endosomal compartment of susceptible cells.
27 ation may be restricted by the quiescence of susceptible cells.
28 infection by preventing virus attachment to susceptible cells.
29 bserved between phenotypically resistant and susceptible cells.
30 variants pseudoviruses increased entry into susceptible cells.
31 sing both phenotypically phage-resistant and susceptible cells.
32 e-4 (DPP4) and is necessary for infection of susceptible cells.
33 eria within a clonal population of otherwise susceptible cells.
34 a relatively low rate of virion infection of susceptible cells.
35 iron from cefiderocol, preventing uptake by susceptible cells.
36 the same outer-membrane transporter to enter susceptible cells.
37 cysteines are necessary for McpM to inhibit susceptible cells.
38 anisms associated with the entry of EAV into susceptible cells.
39 ubsequently confer cancer stemness traits to susceptible cells.
40 e required for facilitating virus entry into susceptible cells.
41 te degradation in the malignant hyperthermia-susceptible cells.
42 s essential for EV-D68 to bind to and infect susceptible cells.
43 ultimately leads to premature senescence of susceptible cells.
44 rus type 1 (HTLV-1) and can spread HTLV-1 to susceptible cells.
45 us was recovered after RNA transfection into susceptible cells.
46 virus particles which can be transmitted to susceptible cells.
47 tibodies that neutralize viral attachment to susceptible cells.
48 d viral integration and replication in HIV-1-susceptible cells.
49 ch are expressed to various degrees in HIV-1 susceptible cells.
50 ing transfection and subsequent infection of susceptible cells.
51 infect intraepithelial and subepithelial HIV-susceptible cells.
52 establishes sustained latent persistence in susceptible cells.
53 subunits that bind globotriaosylceramide on susceptible cells.
54 p53] host mRNA export following infection of susceptible cells.
55 inheritance due to loss of heterozygosity in susceptible cells.
56 icrodomains for entry into and egress out of susceptible cells.
57 ure of Etx pore assembled on the membrane of susceptible cells.
58 xhibited similar one-step growth kinetics in susceptible cells.
59 tors and induces primarily necrotic death in susceptible cells.
60 s B virus (HBV) in attachment and entry into susceptible cells.
61 not needed for HBV attachment and entry into susceptible cells.
62 hrough binding the proteoglycan receptors of susceptible cells.
63 had infected the same small subpopulation of susceptible cells.
64 mplex intracellular pathway in order to kill susceptible cells.
65 verting enzyme 2, the functional receptor on susceptible cells.
66 terminal repeat of p65 and p50 proteins from susceptible cells after exposure to HRF, and the binding
67 ansfer human immunodeficiency virus (HIV) to susceptible cells, although the underlying mechanism is
68 to (gp120/gp41)(3)] attaches the virion to a susceptible cell and induces fusion of viral and cell me
70 n E9 protein toxin to enter the cytoplasm of susceptible cells and kill them by hydrolysing their DNA
72 viruses as they trigger cytotoxicity against susceptible cells and secrete proinflammatory cytokines
73 clear how these three classes of agents kill susceptible cells and whether they utilize the same cyto
74 ixed populations of antibiotic resistant and susceptible cells, and also track pole age and growth ra
75 s-susceptible cells, binds preferentially to susceptible cells, and competes with mature virus for bi
76 sing, differences between O2-tolerant and O2-susceptible cells, and differences between acute and chr
77 for attachment and binding to receptor(s) on susceptible cells, and GP2, which mediates viral and cel
78 the leptin receptor conferred resistance in susceptible cells, and leptin stimulation enhanced prote
79 ereby decreasing the viral burden, access to susceptible cells, and the chronic activation of the imm
80 vo consequences of both the accessibility of susceptible cells, and their heterogeneous susceptibilit
81 ciencies of infection of resistant cells and susceptible cells are similar, but resistant cells (C3H/
82 in AcH in aqueous solution and vesicles from susceptible cells, as well as the ability of trifluoroet
85 , as well as the state of differentiation of susceptible cells at the time of infection, affects the
87 ut switch to the lysogenic cycle later (when susceptible cells become scarce) is favoured over a bet-
88 binds with saturable character to poliovirus-susceptible cells, binds preferentially to susceptible c
89 of the Fas/FasL system induces apoptosis of susceptible cells, but may also lead to nuclear factor k
90 ptosis-inducing ligand) induces apoptosis in susceptible cells by binding to death receptors 4 (DR4)
93 Hepatitis C virus (HCV) gains entry into susceptible cells by interacting with cell surface recep
94 utralizing antibodies block viral entry into susceptible cells by targeting the HIV-1 envelope glycop
102 dic platform was capable of delineating drug susceptible cells, drug tolerant, and drug resistant cel
106 iate the lipid-mediated apoptotic cascade in susceptible cells, failed to either induce PT or release
108 to ensure the maintenance of a local pool of susceptible cells for additional rounds of virus replica
109 in the infant mucosa provide a large pool of susceptible cells for ingested HIV-1 at birth and during
111 The sequence data revealed that the EHV-1-susceptible cells had acquired an E. caballus MHC-I cDNA
112 s in many transformed cells due, in part, to susceptible cells harboring defects in the IFN system.
113 human immunodeficiency virus (HIV) spread to susceptible cells has been documented, there is comparat
116 st in vitro, to promote virus replication in susceptible cells.IMPORTANCE AKAV and SBV are the etiolo
117 riptomic profiling of susceptible versus non-susceptible cells in combination with genome-wide CRISPR
120 ns may contribute to tumor initiation within susceptible cells in the CNS by limiting DNA damage repa
125 curli fibres provide a barrier that protects susceptible cells independent of genes required for biof
127 nveloped virus.IMPORTANCE Virus entry into a susceptible cell is the first step of infection and a si
128 r understanding of how HIV is transmitted to susceptible cells is critical to devise effective strate
129 d by bacteria binds to membrane receptors of susceptible cells, is cleaved proteolytically, attaches
130 brane protein (p38.5) from a prototypical NK-susceptible cell line (K562) that preferentially bound t
132 ells from infected tissues were mixed with a susceptible cell line, the subtype C isolates were outco
135 erlotinib decreased c-fos mRNA levels in the susceptible cell lines A431, CAL27, and HN11; however, b
137 structure and assembly of PaV, we identified susceptible cell lines and developed a reverse genetic s
139 tudied in an attempt to identify potentially susceptible cell lines for virus propagation in vitro an
140 g that use of a combination of different HRV-susceptible cell lines is the best approach for the reco
141 Using genomic approaches, we show that the susceptible cell lines overexpress cytidine deaminase (C
142 SteviX4 induces ferroptotic cell death in susceptible cell lines, and target identification experi
143 KCP and/or K8.1 remained infectious in KSHV-susceptible cell lines, including epithelial, endothelia
148 esistant mitochondria via elimination of Fas-susceptible cells may suggest the existence of a shared
150 are small polypeptides (7-14 kDa) which kill susceptible cells of closely related fungal species.
152 ent modalities such as gene therapy of HIV-1-susceptible cell populations, must be capable of engende
153 ny antineoplastic agents induce apoptosis in susceptible cells raises the possibility that factors af
155 Transfection of these cosmid clones into MDV-susceptible cells resulted in the generation of a recomb
156 n-resistant revertants, isolated from highly susceptible cells, revealed a gene expression signature
157 To further understand how rotaviruses enter susceptible cells, six different polarized epithelial ce
158 R) as the receptor through which they infect susceptible cells, some CVB strains are known for their
159 y intermediate because it accumulates inside susceptible cells soon after infection and drugs which i
163 ation and secretion of H1B from target HIV-1 susceptible cells, suggesting that ubiquitinated H1B is
166 ant cancers contained a higher percentage of susceptible cells than cancers from noncastrated mice.
167 l persisters, a subpopulation of genetically susceptible cells that are normally dormant and tolerant
168 ompetition assays in vitro were performed in susceptible cells that were either interferon type I/III
169 to elute unproductively from the surface of susceptible cells, their precise role remains unclear.
170 ute induction of EphA2 may purge genetically susceptible cells, thereby uncovering a more aggressive
175 We suggest that delivery of sfRNA to new susceptible cells to inhibit type I IFN induction before
178 he minimum inhibitory concentration (MIC) of susceptible cells to the MIC of the least susceptible, s
180 cell activation can be abrogated by exposing susceptible cells (tumor and mycobacteria-infected cells
181 ers in fetal brain development, are the most susceptible cell type for HCMV infection in the fetal br
184 We show that FIPC-1 induces ferroptosis in susceptible cell types and labels cellular proteins in a
185 of regional and developmental variations in susceptible cell types and supportive microenvironments
186 tively high cAMP signaling pathway output in susceptible cell types can elicit DNA replication stress
188 le KSHV establishes latency in virtually all susceptible cell types, LECs support spontaneous express
191 pitopes can lead to increased infectivity of susceptible cells via antibody-dependent enhancement (AD
192 NFalpha family that can trigger apoptosis in susceptible cells via respective death receptors (DRs).
196 heptapeptide facilitates McC transport into susceptible cells, where it is processed releasing a non
197 can be transmitted in cocultures to adherent susceptible cells, which become infected, express viral
198 olyamine depletion limits CVB3 attachment to susceptible cells, which is rescued by incubating virus
199 MDV concurrently loses its ability to infect susceptible cells while gaining the capacity to infect i
201 studies of IFN production after infection of susceptible cells with measles virus (MeV) have often re